Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ivermectin
ECO Animal Health Europe Limited
QP54AA01
Ivermectin
6 milligram(s)/gram
Premix for medicated feeding stuff
POM: Prescription Only Medicine as defined in relevant national legislation
ivermectin
Authorised
2015-04-10
Health Products Regulatory Authority 05 February 2021 CRN009W3P Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Vetimec 6 mg/g Premix for medicated feeding stuff for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Ivermectin 6 mg/g EXCIPIENT(S): For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Premix for medicated feeding stuff Yellow-brown, free-flowing granules 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of nematode or arthropod infections due to: GASTROINTESTINAL ROUNDWORMS _Ascaris suum_ (adults and L4) _Hyostrongylus rubidus_ (adults and L4) _Oesophagostomum_ spp. (adults and L4) _Strongyloides ransomi _(adults)* LUNGWORMS _Metastrongylus_ spp. (adults) LICE _Haematopinus suis_ MANGE MITES _Sarcoptes scabiei_ var. _suis_ _ _ *Given to pregnant sows before farrowing, it effectively controls transmission via milk of _S. ransomi _to piglets. 4.3 CONTRAINDICATIONS Do not use for any other animal species as severe adverse reactions, including fatalities in dogs may occur. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Exposure of treated pigs to infected animals, contaminated premises, soil or pasture may result in re-infestation and re-treatment may be necessary. Since the effect of ivermectin on mange mites is not immediate, avoid direct contact between treated and untreated pigs for at least one week after completion of treatment. Because louse eggs are unaffected by ivermectin and may take up to three weeks to hatch, re-treatment may be necessary. Health Products Regulatory Authority 05 February 2021 CRN009W3P Page 2 of 5 Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. Underdosing, which may be due to underestimation of body weight, misadm Read the complete document